ArticleOncotarget2016

Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.

Minna Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.